Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000322754 | SCV000332955 | likely pathogenic | not provided | 2015-07-09 | criteria provided, single submitter | clinical testing | |
Centogene AG - |
RCV001251035 | SCV001426429 | pathogenic | COG6-congenital disorder of glycosylation | criteria provided, single submitter | clinical testing | ||
Baylor Genetics | RCV001251035 | SCV001524651 | pathogenic | COG6-congenital disorder of glycosylation | 2020-06-03 | criteria provided, single submitter | clinical testing | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. |
Gene |
RCV000322754 | SCV001828048 | pathogenic | not provided | 2022-05-08 | criteria provided, single submitter | clinical testing | RT-PCR analysis shows a significant reduction of the normal transcript and the presence of an aberrant COG6 transcript (Shaheen et al., 2013); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports a deleterious effect on splicing; This variant is associated with the following publications: (PMID: 25558065, 23606727, 26260076, 26077850, 29709711, 28600779, 28742265, 31589614, 29878199, 31130284, 32552793, 32860008) |
Revvity Omics, |
RCV000322754 | SCV003821283 | pathogenic | not provided | 2022-05-18 | criteria provided, single submitter | clinical testing | |
Genomic Medicine Center of Excellence, |
RCV001251035 | SCV004805072 | pathogenic | COG6-congenital disorder of glycosylation | 2024-03-17 | criteria provided, single submitter | research | |
Al Jalila Children’s Genomics Center, |
RCV000050228 | SCV005420403 | pathogenic | Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome | 2024-10-04 | criteria provided, single submitter | research | PM3 (very strong), PS3,PM2,PP1 |
OMIM | RCV000050228 | SCV000082807 | pathogenic | Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome | 2013-07-01 | no assertion criteria provided | literature only | |
Genomic Medicine Center of Excellence, |
RCV000162165 | SCV000196451 | likely pathogenic | Hypohidrosis; Intellectual disability | 2014-12-01 | no assertion criteria provided | research | |
Biochemical Molecular Genetic Laboratory, |
RCV000985030 | SCV001132963 | pathogenic | COG6-related disorder | 2019-08-25 | no assertion criteria provided | clinical testing | |
Prevention |
RCV000985030 | SCV004710980 | pathogenic | COG6-related disorder | 2024-02-14 | no assertion criteria provided | clinical testing | The COG6 c.1167-24A>G variant is predicted to interfere with splicing. This variant was reported in the homozygous state in individuals with COG6-congenital disorder of glycosylation including hypohidrosis and intellectual disability features (Shaheen et al. 2013. PubMed ID: 23606727; Alsubhi et al. 2017. PubMed ID: 28742265; Monies et al. 2017. PubMed ID: 28600779; Monies et al. 2019. PubMed ID: 31130284; Maddirevula et al. 2020. PubMed ID: 32552793; Bertoli-Avella et al. 2021. PubMed ID: 32860008). This variant was reported as one of the founder variants for congenital disorders of glycosylation in Saudi population (Shaheen et al. 2013. PubMed ID: 23606727; Alsubhi et al. 2017. PubMed ID: 28742265). Functional studies showed this variant largely replaces the canonical acceptor site, resulting in pronounced reduction of the normal transcript and consequent deficiency of COG6 protein (Shaheen et al. 2013. PubMed ID: 23606727). This variant has not been reported in a large population database. This variant is interpreted as pathogenic. |